RxDoctor Payments Data

Antonios Tsismenakis, MD

Orthopaedic Surgery · Bangor, MENPI 1942509161

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (34.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Encore Medical, LP accounts for 81.2% of it on its own, with 11 other manufacturers making up the rest. Among orthopaedic surgery clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,260in general payments, 2019–2025

Across 119 payments — averaging $313.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$30K
  • Smith+Nephew$6K
  • Stryker$476
  • Zimmer Biomet$339
  • Pacira Therapeutics, Inc.$117
  • Kairos Surgical Inc$67
  • plus $192 from 6 others

What the payments were for

  • Consulting fees$11,91032%
  • Speaking & faculty fees$7,19319%
  • Travel & lodging$12,97535%
  • Food & beverage$5,18314%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,260 in reported general payments places this provider in the 90th percentile of 111 orthopaedic surgery providers in Maine.

See all orthopaedic surgery providers in Maine

Medicare billing

Part B allowed, 2024
$158,538
Medicare patients
287
Services billed
1,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$4,260
Naproxen50$790
Celecoxib15$722
Famotidine100$645
Tramadol Hcl184$582
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$286
Hydroxyzine Pamoate34$184
Gabapentin71$134
Mupirocin31$122
Amoxicillin144$121
Ibuprofen14$83
Clindamycin Hcl39$37

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bangor

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →